A novel nomogram to predict survival in patients with recurrent nasopharyngeal carcinoma after salvage endoscopic surgery

• Published in: Oral oncology Vol. 111; p. 104922
• Main Authors: Li, Wanpeng, Lu, Hanyu, Liu, Juan, Liu, Quan, Wang, Huan, Zhang, Huankang, Hu, Li, Zhao, Weidong, Gu, Yurong, Li, Houyong, Sun, Xicai, Wang, Dehui
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.12.2020
• Subjects: Endoscopic surgery; Hematology, Oncology, and Palliative Medicine; Nasopharyngeal carcinoma; Nomogram; Otolaryngology; Recurrent; Survival; Nasopharyngeal carcinoma; Endoscopic surgery; Recurrent; Survival; Nomogram
• ISSN: 1368-8375; 1879-0593; 1879-0593
• DOI: 10.1016/j.oraloncology.2020.104922

•229 patients with recurrent NPC were involved in the study.•Six significant prognostic factors were entered into the nomogram.•The C-index of the nomogram was 0.746 in the training cohort.•The nomogram showed its advantage to predict survival of recurrent NPC. To develop and validate a nomogram to predict survival in patients with recurrent nasopharyngeal carcinoma (NPC) after salvage endoscopic surgery. A total of 229 eligible patients with recurrent NPC were divided into training (n = 115) and validation (n = 114) cohorts. A multivariate Cox proportional risk regression model was used to identify significant prognostic factors for overall survival (OS) in the training cohort. A nomogram was then developed based on the regression model. The performance of the nomogram was assessed with regard to discrimination and calibration. Patients were divided into low-risk or high-risk groups based on the risk scores derived from the nomogram. Furthermore, decision curve analysis (DCA) was used to assess the clinical utility of the nomogram. Six significant predictors were identified: diabetes mellitus, body mass index (BMI), neutrophil-to-lymphocyte ratio (NLR), T stage, lymph node metastasis, and tumor necrosis. The nomogram incorporating these six predictors demonstrated favorable discrimination and calibration in the training cohort, with a C-index of 0.746 (95% confidence interval [CI] 0.656–0.836), which was subsequently confirmed in the validation cohort (C-index 0.768 [95% CI 0.675–0.861]). Furthermore, the nomogram successfully distinguished patients into low- and high-risk groups. DCA indicated that the nomogram was clinically useful. The novel nomogram demonstrated its potential as an individual tool to predict survival in patients with recurrent NPC after salvage endoscopic surgery.